FDA approves St Jude's Unify and Fortify cardiac devices
This article was originally published in Clinica
Executive Summary
The US FDA has granted premarket approval (PMA) for St Jude Medical's Unify cardiac resynchronisation therapy defibrillator (CRT-D) and Fortify implantable cardioverter defibrillator (ICD). Unify and Fortify are the smallest devices of their type available, but have similar longevity and power to competing products, St Jude claims. Their small size allows physicians to make a smaller incision when implanting them, reducing procedure times and scarring. The devices also feature "advanced sensing technology" to reduce the risk of inappropriate defibrillation therapy. The St Paul, Minnesota firm CE marked both devices for sale in Europe in February.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.